Medscape InDiscussion: Lung Cancer
Activity Overview
Episode publication activity over the past year
Episodes
S3 Episode 6: NUT Carcinoma: Diagnostic Challenges, Emerging Treatments, and Clinical Trials
09 Jul 2024
Contributed by Lukas
Drs Jacob Sands and Jia Luo discuss NUT carcinoma, including diagnostic challenges, emerging treatments, clinical trial options, and the NUT carcinoma...
S3 Episode 5: Revolutionizing Small Cell Lung Cancer: A Deep Dive into Immunotherapy Advancements With Dr Hossein Borghaei
11 Jun 2024
Contributed by Lukas
Drs Jacob Sands and Hossein Borghaei discuss small cell lung cancer, including breakthroughs and challenges in immunotherapy. Relevant disclosures can...
S3 Episode 4: The Future of Antibody-Drug Conjugates in Lung Cancer Treatment
09 May 2024
Contributed by Lukas
Drs Jacob Sands and Benjamin P. Levy discuss antibody-drug conjugates in lung cancer treatment, including differences in efficacy, toxicity profiles, ...
S3 Episode 3: Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health
11 Apr 2024
Contributed by Lukas
Drs Jacob Sands and Narjust Florez discuss the nuances of treating women with lung cancer, including screening, treatment, and sexual and reproductive...
S3 Episode 2: Improving Lung Cancer Patient Care Through Collaboration, Psychology, and Communication
07 Mar 2024
Contributed by Lukas
Drs Jacob Sands and Donald L. Rosenstein discuss the psychology of lung cancer and how to effectively communicate with patients about diagnosis, treat...
S3 Episode 1: What Are the Latest Improvements in Targeted Therapy Options and Diagnostic Technology for Lung Cancer Patients?
07 Mar 2024
Contributed by Lukas
Drs Jacob Sands and Julia Rotow discuss the latest breakthroughs in lung cancer treatment, including targeted therapy options, toxicities, and diagnos...
S2 Episode 6: How Can Clinicians Recognize and Address Stigma and Bias to Improve Treatment Disparities in Lung Cancer?
15 Jun 2023
Contributed by Lukas
Drs Jacob Sands and Christopher Lathan, MD, discuss stigma, clinician bias, financial toxicity, and treatment disparities in lung cancer, including he...
S2 Episode 5: Immunotherapy, Next-Generation Sequencing, and Shared Decision-Making in the Treatment of Non–Small Cell Lung Cancer
17 May 2023
Contributed by Lukas
Drs Jacob Sands and Stephen V. Liu discuss immunotherapy, biomarkers, next-generation sequencing, shared decision-making, and improving outcomes in th...
S2 Episode 4: Lung Cancer Screening: Where Guidelines and Clinical Judgment Intersect in the Evaluation of Suspicious Nodules
18 Apr 2023
Contributed by Lukas
Drs Jacob Sands and Chi-Fu J. Yang discuss lung cancer screening trials and the intersection of guidelines and clinical judgment in evaluation of susp...
S2 Episode 3: Standard of Care in Perioperative Management of Lung Cancer: The Past, Present, and Future
16 Mar 2023
Contributed by Lukas
Drs Jacob Sands and Jamie Chaft discuss the past, present, and future of perioperative management of lung cancer, including data from recent trials, d...
S2 Episode 2: Young Adults and Lung Cancer: Testing and Treatment Options for a Population That Does Not Qualify for Screening
16 Feb 2023
Contributed by Lukas
Drs Jacob Sands and Julia Rotow discuss genomic testing, treatment options, and clinical trials for young adults who do not qualify for lung cancer sc...
S2 Episode 1: Are We Ready to Use the Word "Cure" When Talking About Small Cell Lung Cancer Treatment?
16 Feb 2023
Contributed by Lukas
Drs Jacob Sands and Jared Weiss discuss subtypes; ongoing clinical trials; durable, ongoing responses to therapy; and the potential for using the word...
S1 Episode 6: The Role of Cultural Humility in Addressing Disparities in Lung Cancer Treatment: How Can Physicians Make a Difference?
13 Dec 2022
Contributed by Lukas
Drs Jacob Sands and Narjust Florez discuss the importance of cultural humility in addressing bias and disparities in lung cancer, including screenings...
S1 Episode 5: Small Cell Lung Cancer: What Are the First-line and Second-line Treatment Options?
15 Nov 2022
Contributed by Lukas
Drs Jacob Sands and Lauren Byers discuss the treatment options for patients diagnosed with small cell lung cancer and the future possibility of durabl...
S1 Episode 4: Managing Lung Cancer With Neoadjuvant and Adjuvant Therapy
13 Oct 2022
Contributed by Lukas
Drs Jacob Sands and Benjamin Levy discuss the management of lung cancer with neoadjuvant and adjuvant therapy and the potential impact of current clin...
S1 Episode 3: Immunotherapy and Lung Cancer Treatment
15 Sep 2022
Contributed by Lukas
Drs Jacob Sands and Jared Weiss discuss immunotherapy, including the importance of genomic testing, recent studies, new regimens, and the future of lu...
S1 Episode 2: Biomarkers and Targeted Therapies for Lung Cancer
11 Aug 2022
Contributed by Lukas
Drs Jacob Sands and Pasi Jänne discuss the effectiveness of biomarkers and targeted therapies for lung cancer. Relevant disclosures can be found with...
S1 Episode 1: What Are the Risks and Benefits of Lung Cancer Screening?
11 Aug 2022
Contributed by Lukas
Drs Jacob Sands and Shawn Regis discuss the risks and benefits of lung cancer screening. Relevant disclosures can be found with the episode show notes...